Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$218.11
+1.24%
Mkt Cap $31.14B
Analyst Ratings
Buy
25
Hold
13
Sell
0
Price Target (129 analysts)
$218.32
Range $185.00 – $260.00
Implied Upside
+0.1%
Consensus $218.32 vs current $218.11